Synvista Therapeutics Inc. (SYI) Stock Could Set New Standards for Healthcare
The management of diabetes is one of the largest therapeutic segments of the Healthcare sector. Surveys have repeated established that modern diets and lifestyles tend to impair glucose metabolism in people. Moreover, some ethnic groups prevalent in emerging economies are genetically more vulnerable to diabetes than mainstream Americans. The business implication is that diabetes management is a large and growing worldwide healthcare segment. Neuropathy and acute cardiac events are serious side-effects of diabetes. The disease may have no apparent symptoms, so large numbers of patients may suffer from the condition without timely detection. This company has a focus on detecting…